Hep Email Update NVHR Applauds Complaint Against Alabama Medicaid for Denial of HCV Treatment for People with Substance Use Disorder “Sobriety restrictions on hepatitis C treatments hinder our ability to properly address the viral hepatitis and overdose syndemic,” said Daniel Raymond, director of policy at the National Viral Hepatitis Roundtable. Advertisement Hepatitis C Treatment Is Effective for People 65 and Older However, older people were more likely to experience adverse events, especially if they used ribavirin. Study Links Synthetic Chemicals to Liver Damage PFAS, synthetic chemicals found in many common products, may be contributing to an increase in liver problems, such as fatty liver disease. Why Won’t More Older Americans Get Their Covid Booster? Approximately 1 in 3 Americans 65 and older who completed their initial vaccination round still have not received a first booster shot. Remembering Naomi Judd as a Powerful Voice for Hepatitis Advocacy Singer Naomi Judd was diagnosed with hepatitis C in 1990 and cured eight years later. She spoke out for those with liver disease. The Hep Magazine Archives To read past issues of Hep, click the link! Advertisement Science News Study Links Synthetic Chemicals to Liver Damage Still Few Answers as Kids Hepatitis Outbreak Spreads Hepatitis C Treatment Is Effective for People 65 and Older Fatty Liver Disease Increased During COVID-19 Pandemic Newsfeed Remembering Naomi Judd as a Powerful Voice for Hepatitis Advocacy Should Medical Staff Still Be Tracked to Protect Patients Against Hepatitis C? $5M in Federal Funds to End HIV and Hepatitis C Among American Indians Hepatitis and HIV Groups Protest 340B Restrictions to Low-Cost Drugs Science News Study Links Synthetic Chemicals to Liver Damage Still Few Answers as Kids Hepatitis Outbreak Spreads Hepatitis C Treatment Is Effective for People 65 and Older Fatty Liver Disease Increased During COVID-19 Pandemic Newsfeed Remembering Naomi Judd as a Powerful Voice for Hepatitis Advocacy Should Medical Staff Still Be Tracked to Protect Patients Against Hepatitis C? $5M in Federal Funds to End HIV and Hepatitis C Among American Indians Hepatitis and HIV Groups Protest 340B Restrictions to Low-Cost Drugs

You are receiving this email because you opted in at one of our websites. At your request, this message was sent to newsletter@newslettercollector.com by update@hepmag.com. Please remember to add update@hepmag.com to your email address book, so that these updates aren't blocked as spam.

To change your subscription information and preferences, please visit your personal preferences page. Or you can unsubscribe completely from this list.

To forward this message, please do not use the forward button of your email application, because this message was made specifically for you only. Instead use the forward page in our newsletter system.

Did you receive this email from a friend? You can subscribe and you will receive our next newsletter directly to your inbox.

Our mailing address is: